Aspirin-free antiplatelet regimens after PCI: When is it best to stop aspirin and who could ultimately benefit?

Mariusz Tomaniak; Robert F. Storey; Patrick W. Serruys

doi:10.4244/EIJY19M10_01

Aspirin-free antiplatelet regimens after PCI: When is it best to stop aspirin and who could ultimately benefit?

Mariusz Tomaniak, Robert F. Storey, Patrick W. Serruys

Research output: Contribution to a Journal (Peer & Non Peer) › Review article › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	1125-1129
Number of pages	5
Journal	EuroIntervention
Volume	15
Issue number	13
DOIs	https://doi.org/10.4244/EIJY19M10_01
Publication status	Published - Jan 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4244/EIJY19M10_01

Cite this

@article{10d823e2a598410bbed82ac77c70a55f,

title = "Aspirin-free antiplatelet regimens after PCI: When is it best to stop aspirin and who could ultimately benefit?",

author = "Mariusz Tomaniak and Storey, \{Robert F.\} and Serruys, \{Patrick W.\}",

year = "2020",

month = jan,

doi = "10.4244/EIJY19M10\_01",

language = "English",

volume = "15",

pages = "1125--1129",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "Europa Group",

number = "13",

}

TY - JOUR

T1 - Aspirin-free antiplatelet regimens after PCI

T2 - When is it best to stop aspirin and who could ultimately benefit?

AU - Tomaniak, Mariusz

AU - Storey, Robert F.

AU - Serruys, Patrick W.

PY - 2020/1

Y1 - 2020/1

UR - https://www.scopus.com/pages/publications/85077706249

U2 - 10.4244/EIJY19M10_01

DO - 10.4244/EIJY19M10_01

M3 - Review article

C2 - 31595880

AN - SCOPUS:85077706249

SN - 1774-024X

VL - 15

SP - 1125

EP - 1129

JO - EuroIntervention

JF - EuroIntervention

IS - 13

ER -

Aspirin-free antiplatelet regimens after PCI: When is it best to stop aspirin and who could ultimately benefit?

UN SDGs

Access to Document

Other files and links

Cite this